申请人:Abe Masatoshi
公开号:US20050164989A1
公开(公告)日:2005-07-28
There are disclosed a novel α-amino-N-(diaminophosphinyl)lactam derivative represented by general formula (1):
wherein, for example, A is a hydrogen atom or a substituent such as a lower alkyl group or the like; W, X, Y and Z are independently a hydrogen atom or a substituent such as a lower alkyl group, aryl group, arylacyl group, arylaminocarbonyl group or the like; and Q is —(CH
2
)
n
— wherein n is 0 to 3, or its salt, and a therapeutic agent and a prophylactic agent for myelosuppression, a therapeutic agent for infectious diseases, an agent for increasing the number of leukocytes and a dipeptidyl peptidase IV inhibitor which comprise the above-mentioned derivative or salt thereof as an active ingredient.
公开了一种新型α-氨基-N-(二氨基膦基)内酰胺衍生物,其通式表示为(1):其中,例如,A是氢原子或取代基,例如较低的烷基或类似物; W、X、Y和Z分别是氢原子或取代基,例如较低的烷基、芳基、芳基酰基、芳基氨基甲酰基或类似物; Q是—(CH2)n—,其中n为0到3,或其盐,并且包括上述衍生物或其盐作为活性成分的治疗剂和预防剂,用于骨髓抑制、传染病治疗剂、增加白细胞数的剂和二肽基肽酶IV抑制剂。